Migraine

DENVER – More data are still needed on proper dosing of patients with eptinezumab for migraine prevention, Rami Apelian, MD, MPH, FAES, said at the American Headache Society’s annual scientific meeting.

Children born to mothers who used triptans for their migraines during pregnancy did not have a greater risk for ADHD symptoms or diagnosis at 5 years of age, according to a Norwegian registry-based study.

DENVER — Verapamil was shown to be tolerable for migraine prevention at a maximum dose of 20 mg to 480 mg per day, Yi-Chieh Chen, PharmD, said at the American Headache Society’s annual scientific meeting.

DENVER — A child’s understanding of a migraine may not align with diagnostic criteria, highlighting the need for greater transparency in defining “migraine day,” Danielle Kellier, BS, said at the American Headache Society’s annual meeting.

DENVER — Although migraine prevalence has remained stable over the past 30 years, measures of burden, including MIDAS scores, have steadily increased, Fred Cohen, MD, said at the American Headache Society’s annual scientific meeting.

DENVER — Nerivio, a noninvasive digital therapeutic device, provided migraine pain relief within 2 hours in 67% of adults and 71% of adolescents, Alon Ironi said at the American Headache Society’s annual scientific meeting.

DENVER – Individuals who had migraine with aura were more likely to have atrial fibrillation compared with those who had a migraine without aura, a presenter said at the American Headache Society annual meeting.

DENVER — Trudhesa nasal spray provided pain relief for up to three consecutive migraine attacks in an open-label, 52-week phase 3 trial, researchers said at the American Headache Society annual scientific meeting.

DENVER — Psychedelic use, specifically psilocybin, is effective in treating cluster headaches and migraines, Emmanuelle Schindler, MD, PhD, said at the American Headache Society annual scientific meeting.

DENVER — Monoclonal antibodies have shown promise as an emerging treatment for migraine, Stephanie J. Nahas, MD, MSEd, FAHS, FAAN, said at the American Headache Society annual scientific meeting.